Evidence map›Paper›PMID 19567873›Full record

ArticleThe Journal of biological chemistry2009

Identification of the active form of endothelial lipase, a homodimer in a head-to-tail conformation.

Nathalie Griffon, Weijin Jin, Thomas J Petty, John Millar, Karen O Badellino, Jeffery G Saven, Dawn H Marchadier, Ellis S Kempner, Jeffrey Billheimer, Jane M Glick and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. ApoJ regulates endothelial lipase activity and stability.Protein science : a publication of the Protein Society · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. NAD(H)-mediated tetramerization controls the activity ofProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Review
  8. Article
  9. Endoplasmic reticulum quality control in lipoprotein metabolism.Molecular and cellular endocrinology · 2019
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Comparative studies of vertebrate lipoprotein lipase: a key enzyme of very low density lipoprotein metabolism.Comparative biochemistry and physiology. Part D, Genomics & proteomics · 2011
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Nathalie GriffonInstitute for Translational Medicine and Therapeutics, Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Weijin Jin
Thomas J Petty
John Millar
Karen O Badellino
Jeffery G Saven
Dawn H Marchadier
Ellis S Kempner
Jeffrey Billheimer
Jane M Glick
Daniel J Rader
University of Pennsylvania · USNational Institute of Arthritis and Musculoskeletal and Skin Diseases · US

Funding

HDL metabolism: Influence of extracellular lipasesR37HL055323 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI RADER, DANIEL JAMES · 2009 to 2018
$4.0M
High Density Lipoprotein Metabolism Influence of Extracellular PhospholipasesR01HL055323 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI RADER, DANIEL JAMES · 1996 to 2009
$3.0M
NHLBI NIH HHS HL55323NHLBI NIH HHS R01 HL055323NHLBI NIH HHS R37 HL055323
6 · The paper itself

Abstract

Endothelial lipase (EL) is a member of a subfamily of lipases that act on triglycerides and phospholipids in plasma lipoproteins, which also includes lipoprotein lipase and hepatic lipase. EL has a tropism for high density lipoprotein, and its level of phospholipase activity is similar to its level of triglyceride lipase activity. Inhibition or loss-of-function of EL in mice results in an increase in high density lipoprotein cholesterol, making it a potential therapeutic target. Although hepatic lipase and lipoprotein lipase have been shown to function as homodimers, the active form of EL is not known. In these studies, the size and conformation of the active form of EL were determined. Immunoprecipitation experiments suggested oligomerization. Ultracentrifugation experiments showed that the active form of EL had a molecular weight higher than the molecular weight of a simple monomer but less than a dimer. A construct encoding a covalent head-to-tail homodimer of EL (EL-EL) was expressed and had similar lipolytic activity to EL. The functional molecular weights determined by radiation inactivation were similar for EL and the covalent homodimer EL-EL. We previously showed that EL could be cleaved by proprotein convertases, such as PC5, resulting in loss of activity. In cells overexpressing PC5, the covalent homodimeric EL-EL appeared to be more stable, with reduced cleavage and conserved lipolytic activity. A comparative model obtained using other lipase structures suggests a structure for the head-to-tail EL homodimer that is consistent with the experimental findings. These data confirm the hypothesis that EL is active as a homodimer in head-to-tail conformation.

Indexed as

Protein EngineeringCell LineDimerizationHumansLipaseMolecular ConformationProtein ConformationLipaseLIPG protein, human

Identifiers

PMID19567873
PMCPMC2749106
OpenAlexW2004276430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.